1 April 2015

Sinclair IS Pharma cuts loss 

22/09/2011 Robert Tyerman

Recently-merged Sinclair IS Pharma (SPH.L) has cut annual losses 31 per cent to £11.7 million and launched an Asia-Pacific marketing drive. The AIM-quoted company, which specialises in oral health, dermatology and wound care, increased turnover 19 per cent to nearly £33 million in the year to June.

Steered by entrepreneurial chief executive Chris Spooner, Sinclair, whose losses before exceptional items rose 14.5 per cent to £5.8 million, achieved several product launches last year. The company introduced its Autopiclair eczema and dermatitis cream into France, a market which returned to growth last year with a 21 per cent turnover gain to £12.5 million, and took its Kelo-cote scar reduction formulation into several European markets.

Outgoing chairman John Gregory says the merger of Sinclair Pharma with IS Pharma should lead to annual cost savings of £1 million and has already started to pay off more positively, as with a marketing agreement for the company's Episil treatment for oral mucositis pain. Grahame Cook, already a Sinclair director, will now chair the company, which has already launched two dermatology products in seven Asia-Pacific countries under its partnership with Singapore-based Invida Holdings, a leader in commercialising bio-pharmaceutical and healthcare products in the region.

Sinclair, which ended the financial year with £5 million cash, now has a 'bio-film busting' mouthwash for sale in the USA under the PerioShield banner through an agreement with Sunstar Americas and has several new products in the pipeline. Highlighted by Growth Company Investor at 28p last autumn, Sinclair shares have eased to 24p, valuing the company at £93.3 million, but could still outperform some sector peers over the medium term.

Tags: AIM market, Asia-Pacifuyc, Autopiclair, Chris Spooner, Dermatology, Wound care

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2014

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1,044 AIM-quoted companies. The full report is available to order for £365 + VAT. Click here for more info

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

The company received the proceeds as part of a wider consortium

652k on the Horizon 26/03/2015

Horizon Discovery Group (AIM:HZD), a provider of research tools and services for genomics research, has received £652,000 as part of a consortium. 

Tags: Biotech, Fundraising

Pantheon drilling ahead 26/03/2015

AIM-quoted US-focused oil and gas play Pantheon Resources (AIM:PANR) has updated investors on its latest activities.

Tags: Oil and gas, USA

Petroceltic leaving Kurdistan 26/03/2015

Irish oil explorer Petroceltic International (AIM:PCI) reported that it was ending its involvement in the Kurdistan region of Iraq.

Tags: Iraq, Oil and gas

Plexus Holdings announces Chinese deal 26/03/2015

Scottish oil technology specialist Plexus Holdings (AIM:POS) has announced a partnership with Chinese oil services provider Yantai Jereh.

Tags: China, Oil and gas

AFC wins German permit 26/03/2015

Alkaline fuel cell developer AFC Energy (AIM:AFC) has won a permit to build the 'world's first alkaline fuel cell facility' in Germany.

Tags: Germany

Karelian makes major find 20/03/2015

Finland-focused Karliean Diamonds (AIM:KDR) has discovered a potential new diamond source.

Tags: Diamond mining

More News